Mainz Biomed NV

General ticker "MYNZ" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $97.5M

Mainz Biomed NV follows the US Stock Market performance with the rate: 23.7%.

Estimated limits based on current volatility of 13.6%: low 4.69$, high 6.16$

Factors to consider:

  • Earnings expected soon, date: 2024-12-26 bmo
  • Current price 166.4% above estimated high

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [0.48$, 1.86$]
  • 2024-12-30 to 2025-12-30 estimated range: [0.42$, 1.41$]

Financial Metrics affecting the MYNZ estimates:

  • Negative: Non-GAAP EPS, $ of -1.80 <= 0.10
  • Negative: Operating profit margin, % of -96.75 <= 1.03
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -54.09 <= 2.35
  • Negative: Industry earnings per price (median), % of -26.04 <= 1.31

Similar symbols

Short-term MYNZ quotes

Long-term MYNZ plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.58MM $0.53MM $0.90MM
Operating Expenses $9.96MM $26.70MM $27.54MM
Operating Income $-9.38MM $-26.17MM $-26.64MM
Non-Operating Income $-2.32MM $-0.21MM $0.35MM
Interest Expense $0.34MM $0.29MM $0.81MM
R&D Expense $0.47MM $3.66MM $9.59MM
Income(Loss) $-11.70MM $-26.39MM $-26.30MM
Taxes $0.38MM $0.07MM $0.00MM
Profit(Loss) $-12.07MM $-26.45MM $-26.30MM
Stockholders Equity $6.36MM $14.10MM $3.25MM
Assets $10.04MM $20.24MM $15.41MM
Operating Cash Flow $-3.22MM $-14.77MM $-21.94MM
Capital expenditure $0.02MM $0.66MM $1.90MM
Investing Cash Flow $1.20MM $-0.66MM $-1.90MM
Financing Cash Flow $10.61MM $23.94MM $14.23MM
Earnings Per Share* $-1.67 $-1.87 $-1.62

* EPS are Split Adjusted, recent splits may be reflected with a delay.